| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Microbiology, Pennsylvania State University, University Park, Pennsylvania 16802 and Albert Einstein Medical Center, Philadelphia, Pennsylvania 19141
Abstract
Measurements of lymphocyte mediated cytolysis of allogeneic target cells (C57BL/6 EL4) by sensitized BALB/c spleen cells revealed a rapid depression of this in vitro correlate of cellular immunity after infection with Friend leukemia virus (FLV). Immunosuppression occurred with infection either before or after alloantigen sensitization. Cell-mediated cytotoxicity by sensitized lymphocytes from the leukemia resistant C57BL/6 strain for DBA/2 mastocytoma cells was unimpaired when FLV was administered after immunization. However, a significant, but transient, depression of the response was observed when C57BL/6 mice were infected 4 days before immunization, but not at 8 or more days before immunization. A kinetic analysis of the cytolysis indicated that there was a decreased number of cytolytic effectors present in the spleens of the FLV-infected BALB/c mice rather than a diminution of the lytic efficiency of the cytolytic cells. The cytolytic activity carried out by the remaining effectors still occurred via a single interaction between a target cell and a sensitized lymphocyte as in the noninfected mice. The lowered cytotoxicity by BALB/c lymphocytes was proportional to the infecting dose of FLV and could not be accounted for by a simple dilution of effector cells with neoplastic cells. The number of cytolytic lymphocytes decreased logarithmically with time after FLV infection. These results demonstrate that FLV is capable of interfering with a T cell (
-bearing) dependent event as well as the B cell function of antibody formation. The depression of cell-mediated immunity by infection with FLV after immunization clearly contrasts with the absence of depression of humoral antibody formation when FLV is administered after antigen.
Footnotes
1 This research was supported in part by Grant IC-19G from the American Cancer Society, Inc.
2 In partial fulfillment of the requirements for the degree of Doctor of Philosophy, Department of Microbiology, Pennsylvania State University. Present address: Department of Immunology, Rush Medical College, Chicago, Illinois 60612.
This article has been cited by other articles:
|
|
 |
|
  K. J. Hasenkrug and B. Chesebro Immunity to retroviral infection: The Friend virus model PNAS, July 22, 1997; 94(15): 7811 - 7816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ting, S. Tsai, and M. Rogers Host control of tumor growth Science, August 5, 1977; 197(4303): 571 - 573. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
